NHI
Income statement / Annual
Last year (2024), National Health Investors, Inc.'s total revenue was $335.18 M,
an increase of 4.80% from the previous year.
In 2024, National Health Investors, Inc.'s net income was $137.99 M.
See National Health Investors, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$335.18 M |
$319.84 M |
$278.19 M |
$298.72 M |
$332.81 M |
$318.08 M |
$294.61 M |
$278.66 M |
$248.50 M |
$228.99 M |
| Cost of Revenue |
$11.17 M
|
$11.51 M
|
$9.79 M
|
$11.64 M
|
$9.65 M
|
$5.80 M
|
$1.17 M
|
$960.00 K
|
$1.01 M
|
$985.00 K
|
| Gross Profit |
$324.02 M
|
$308.32 M
|
$268.41 M
|
$287.08 M
|
$323.16 M
|
$312.28 M
|
$293.45 M
|
$277.70 M
|
$247.49 M
|
$228.00 M
|
| Gross Profit Ratio |
0.97
|
0.96
|
0.96
|
0.96
|
0.97
|
0.98
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.52
|
$0.58
|
$0.65
|
$0.00
|
| General & Administrative Expenses |
$21.79 M
|
$19.82 M
|
$25.32 M
|
$19.34 M
|
$14.56 M
|
$13.91 M
|
$12.86 M
|
$12.71 M
|
$10.20 M
|
$10.98 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$21.79 M
|
$19.82 M
|
$25.32 M
|
$19.34 M
|
$14.56 M
|
$13.91 M
|
$12.86 M
|
$12.71 M
|
$10.20 M
|
$10.98 M
|
| Other Expenses |
$118.37 M
|
$109.71 M
|
$110.32 M
|
$82.49 M
|
$83.68 M
|
$78.37 M
|
$71.35 M
|
$67.17 M
|
$1.66 M
|
$53.16 M
|
| Operating Expenses |
$140.16 M
|
$129.53 M
|
$135.64 M
|
$101.83 M
|
$98.24 M
|
$92.27 M
|
$85.37 M
|
$80.84 M
|
$70.77 M
|
$65.13 M
|
| Cost And Expenses |
$151.33 M
|
$141.04 M
|
$145.43 M
|
$113.46 M
|
$107.89 M
|
$98.07 M
|
$85.37 M
|
$80.84 M
|
$70.77 M
|
$65.13 M
|
| Interest Income |
$0.00
|
-$2.65 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$18.00 K
|
$0.00
|
| Interest Expense |
$56.12 M
|
$55.51 M
|
$42.44 M
|
$48.11 M
|
$0.00
|
$56.30 M
|
$49.06 M
|
$0.00
|
$43.11 M
|
$0.00
|
| Depreciation & Amortization |
$71.44 M
|
$69.97 M
|
$70.88 M
|
$80.80 M
|
$83.15 M
|
$76.82 M
|
$89.79 M
|
$79.96 M
|
$86.12 M
|
$53.16 M
|
| EBITDA |
$264.16 M |
$259.87 M |
$178.73 M |
$240.94 M |
$318.00 M |
$290.79 M |
$280.59 M |
$264.99 M |
$236.08 M |
$179.36 M |
| EBITDA Ratio |
0.79
|
0.81
|
0.64
|
0.81
|
0.96
|
0.91
|
0.95
|
0.95
|
0.95
|
0.78
|
| Operating Income Ratio |
0.55
|
0.56
|
0.48
|
0.62
|
0.68
|
0.69
|
0.71
|
0.71
|
0.72
|
0.72
|
| Total Other Income/Expenses Net |
-$47.26 M
|
-$44.41 M
|
-$67.35 M
|
-$73.22 M
|
-$39.61 M
|
-$59.56 M
|
-$49.94 M
|
-$38.45 M
|
-$74.13 M
|
-$66.10 M
|
| Income Before Tax |
$136.59 M
|
$134.38 M
|
$65.41 M
|
$112.03 M
|
$185.31 M
|
$160.45 M
|
$154.33 M
|
$159.37 M
|
$153.47 M
|
$149.61 M
|
| Income Before Tax Ratio |
0.41
|
0.42
|
0.24
|
0.38
|
0.56
|
0.5
|
0.52
|
0.57
|
0.62
|
0.65
|
| Income Tax Expense |
-$45.00 K
|
$0.00
|
-$89.00 K
|
$66.00 K
|
$0.00
|
$0.00
|
-$9.17 M
|
$0.00
|
$749.00 K
|
-$707.00 K
|
| Net Income |
$137.99 M
|
$135.65 M
|
$66.40 M
|
$111.80 M
|
$185.13 M
|
$160.46 M
|
$154.33 M
|
$159.37 M
|
$151.54 M
|
$148.86 M
|
| Net Income Ratio |
0.41
|
0.42
|
0.24
|
0.37
|
0.56
|
0.5
|
0.52
|
0.57
|
0.61
|
0.65
|
| EPS |
3.14 |
3.13 |
0.52 |
1.36 |
3.03 |
2.4 |
3.68 |
3.9 |
3.88 |
3.96 |
| EPS Diluted |
3.13 |
3.13 |
0.51 |
1.36 |
3.03 |
2.38 |
3.67 |
3.87 |
3.87 |
3.95 |
| Weighted Average Shares Out |
$43.85 M
|
$43.39 M
|
$44.77 M
|
$45.71 M
|
$44.70 M
|
$43.42 M
|
$41.94 M
|
$40.89 M
|
$39.01 M
|
$37.60 M
|
| Weighted Average Shares Out Diluted |
$44.10 M
|
$43.39 M
|
$44.79 M
|
$45.73 M
|
$44.70 M
|
$43.70 M
|
$42.09 M
|
$41.15 M
|
$39.16 M
|
$37.64 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
